Quest Diagnostics Incorporated Buyback
OLI recorded this information on 2/2/2023
Company:
Quest Diagnostics Incorporated
Buyback:
DGX buyback
$Amount Authorized:
$1,311,000,000
Buyback Details:
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the Company's Board of Directors has authorized a 7.6% increase in its quarterly dividend from $0.66 to $0.71 per share. The increase is effective with the dividend payable on April 24, 2023 to shareholders of record of Quest Diagnostics common stock on April 10, 2023. With the increase, the annual dividend will be $2.84 per share. The company has raised its dividend annually since 2011. Additionally, the Board of Directors has increased the Company's share repurchase authorization by $1 billion. The increased authority is in addition to the $311 million that was available as of December 31, 2022 under the Company's share repurchase program.
Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
Quest Diagnostics SEC Filing Email Alerts Service
Open the DGX Page at The Online Investor »
|
Open the DGX Page at The Online Investor (in a new window) »
Free DGX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.53 out of 4) 6th percentile
(ranked lower than approx. 94% of all stocks covered)
Analysts' Target Price: DGX Stock Forecast Based on Zacks ABR data; powered by Xignite |